-
341
-
342
-
343
-
344
-
345
-
346
-
347
Analysis of Diabetes Apps to Assess Privacy-Related Permissions: Systematic Search of Apps
منشور في 2021"…Accordingly, the availability of mobile apps for diabetes has been steadily increasing. Most of the previous reviews of diabetes apps have focused on the apps’ features and their alignment with clinical guidelines. …"
-
348
-
349
-
350
Fermentation-induced modifications to the structural, surface, and functional properties of quinoa proteins
منشور في 2025"…The fermentation process induces structural modifications in QPs, thereby enhancing their surface properties and functional attributes. Using advanced analytical techniques, such as ultraviolet, fluorescence, and FT-IR spectra, it has been demonstrated that fermented QPs exhibit significant structural changes (P < 0.05) compared to unfermented QPs. …"
-
351
-
352
-
353
Predictors of Mortality in Veno-Arterial Extracorporeal Membrane Oxygenation Regardless of Early Left Ventricular Unloading: A National Experience
منشور في 2025"…In-hospital 30-day mortality occurred in 42.7% among those who received VA-ECMO support regardless of IABP use, while it was 46.9% among those receiving early LV unloading with IABP. The significant positive predictors of mortality with VA-ECMO regardless of IABP in CS were CPR > 20 minutes (aOR 14.74, 95% CI 2.02-107.41; p-value= 0.008), older age (i.e., greater than 55 years) and LM disease of more than 50% stenosis were associated with a fourfold increase in the odds of mortality while on VA-ECMO. …"
-
354
-
355
-
356
Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative
منشور في 2025"…The study measured antiplatelet prescribing patterns and identified clinically significant gene-drug interactions. </p><h3 dir="ltr">Findings</h3><p dir="ltr">Out of 376 patients tested, 283 patients received PGx-guided recommendations for anti-platelet therapy. …"
-
357
-
358
-
359
-
360
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?
منشور في 2024"…Despite the correlation between low high-density lipoprotein cholesterol (HDLC) and heightened CVD risk, HDL-raising therapies have yet to showcase significant clinical benefits. Furthermore, evidence from epidemiological and genetic studies reveals that not only low HDL-C levels, but also very high levels of HDL-C are linked to increased risk of CVD. …"